Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Zealand Pharma Announces Positive Phase 1A Topline Results With Kv1.3 Channel Blocker Zp9830

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    18/02/2026 06:36
    Feb 18 (Reuters) - Zealand Pharma A/S ZELA.CO:

ANNOUNCES POSITIVE PHASE 1A TOPLINE RESULTS WITH KV1.3 CHANNEL BLOCKER ZP9830

ZP9830 WAS WELL TOLERATED IN THIS SINGLE ASCENDING DOSE TRIAL, WITH NO DOSE-LIMITING SAFETY FINDINGS OR OTHER SAFETY CONCERNS OBSERVED

Source text: ID:nGNX3XqDNn

Further company coverage: ZELA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Zealand Pharma A/S

    See all news